Potential Aprea Therapeutics, Inc. (NASDAQ:APRE) shareholders may wish to note that the Independent Director, Marc Duey, recently bought US$132k worth of stock, paying US$4.39 for each share. That's a...
Source LinkPotential Aprea Therapeutics, Inc. (NASDAQ:APRE) shareholders may wish to note that the Independent Director, Marc Duey, recently bought US$132k worth of stock, paying US$4.39 for each share. That's a...
Source Link
Comments